Novel Agents Versus Conventional Drugs for the Treatment of Relapsed Multiple Myeloma Patients: Experience of a Single Center over the Last 25 Years

被引：0
|
作者：
Grammatico, Sara [1 ]
Lisi, Elisabetta [1 ]
Cesini, Laura [1 ]
Vallone, Maria Letizia [1 ]
Capria, Saveria [1 ]
Foa, Robin [1 ]
Petrucci, Maria Teresa [1 ]
机构：
[1] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Hematol, Rome, Italy
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Poor outcomes of immunoglobulin D multiple myeloma patients in the era of novel agents: a single-center experience
    Zhao, Qian
    Li, Feng
    Song, Ping
    Zhou, Xiaogang
    An, Zhiming
    Mei, Jiangang
    Shao, Jingjing
    Li, Hanqing
    Wang, Xuli
    Guo, Xing
    Zhai, Yongping
    CANCER COMMUNICATIONS, 2019, 39 (01)
  • [22] Novel investigational drugs active as single agents in multiple myeloma
    D'Agostino, Mattia
    Salvini, Marco
    Palumbo, Antonio
    Larocca, Alessandra
    Gay, Francesca
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (06) : 699 - 711
  • [23] EXPERIENCE OF A CENTER WITH DVD SCHEME IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Lopez Olga, Perez
    Jose Antonio, Marcos Rodriguez
    Velasco Nazaret, Dominguez
    Millan Rafael, Duro
    Fernandez Alicia, Rodriguez
    HAEMATOLOGICA, 2021, 106 (10) : 344 - 344
  • [24] Bortezomib in relapsed/refractory myeloma patients: A single-center experience
    Grasso, M.
    Tavera, S.
    Bonferroni, M.
    Calvi, R.
    Rapezzi, D.
    Gallamini, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 149 - 150
  • [25] Bortezomid in association therapy in relapsed, refractory multiple myeloma: Experience of a single center
    Buquicchio, C.
    Iacobazzi, A.
    Tarantini, G.
    Ciuffreda, L.
    Desantis, G.
    Santorsola, D.
    Riezzo, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 151 - 151
  • [26] BORTEZOMIB MAINTENANCE TREATMENT IN PATIENTS WITH MULTIPLE MYELOMA-A SINGLE CENTER EXPERIENCE
    Micheva, I.
    Dimitrova, S.
    Rachev, R.
    Varbanov, H.
    Mehmed, M.
    Gerov, V.
    Antonov, A.
    Gercheva, L.
    HAEMATOLOGICA, 2016, 101 : 796 - 796
  • [27] The Role of Novel Agents on Reversibility of Renal Impairment in Newly Diagnosed Patients with Multiple Myeloma; a Single Center Experience on 112 Patients
    Dimopoulos, Meletios A.
    Roussou, Maria
    Gkotzamanidou, Maria
    Psimenou, Erasmia
    Mparmparoussi, Despoina
    Matsouka, Charis
    Terpos, Evangelos
    Kastritis, Efstathios
    BLOOD, 2011, 118 (21) : 1694 - 1694
  • [28] Autologous Re-Transplantation for Patients with Relapsed Multiple Myeloma: A Single Center Experience with 200 Patients.
    Neben, Kai
    Sellner, Leopold
    Heiss, Christiane
    Benner, Axel
    Raab, Marc S.
    Hillengass, Jens
    Hose, Dirk
    Lehners, Nicola
    Egerer, Gerlinde
    Ho, Anthony D.
    Goldschmidt, Hartmut
    BLOOD, 2012, 120 (21)
  • [29] A single-center treatment sequencing analysis in patients with relapsed/refractory multiple myeloma (RRMM)
    Kumar, Swarup
    Clark, Jackson
    Alvarez-Soto, Alvaro
    El Warrak, Samantha
    Kumar, Shruthi
    Braish, Julie
    Reddy, Aswanth
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S190 - S191
  • [30] Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma, a Real-World Single Center Experience
    Hultcrantz, Malin
    Derkach, Andriy
    Hassoun, Hani
    Korde, Neha
    Maclachlan, Kylee H.
    Mailankody, Sham
    Patel, Dhwani
    Shah, Urvi A.
    Tan, Carlyn
    Akhlaghi, Theresia
    Hamadeh, Issam S.
    Chung, David J.
    Lahoud, Oscar B.
    Landau, Heather
    Scordo, Michael
    Shah, Gunjan L.
    Giralt, Sergio A.
    Lesokhin, Alexander M.
    Usmani, Saad
    BLOOD, 2022, 140 : 7246 - 7248
12345